ATLASIndaptus Therapeutics (INDP) earnings date: Nov 11, 2026
Indaptus Therapeutics (INDP) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 11, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on INDP
| Last price | $3.48 (+12.6%) |
|---|---|
| Normal 1-day range (±1σ) | ±8.6% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Indaptus Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Indaptus Therapeutics reports on Nov 11, 2026. One email the day before, with ATLAS’s read on Indaptus Therapeutics. You can switch it off at any time.
Alert me before INDP reportsFree to start. Creating an account takes under a minute.
Notify me when Indaptus Therapeutics reports
Track INDP free Add Indaptus Therapeutics to a free ATLAS watchlist and see its next report date in one place.
INDP earnings at a glance
| Next report (confirmed) | Wed, Nov 11, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| Last report | May 27, 2026 · Beat |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | -12.8% |
| Average move around a report | ±14.3% (last 5) |
| Sector | Healthcare · Biotechnology |
Indaptus Therapeutics earnings history: last 5 reports
Indaptus Therapeutics last reported on May 27, 2026: EPS of $1.47 against an estimate of $1.28 (+14.8% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| May 27, 2026 | $1.28 | $1.47 | +14.8% | Beat | +29.7% |
| Mar 17, 2026 | -$4.36 | -$9.19 | -110.8% | Miss | +6.9% |
| Jan 27, 2026 | $2.20 | $2.38 | +8.2% | Beat | -9.1% |
| Nov 12, 2025 | -$4.17 | -$2.98 | +28.5% | Beat | +8.8% |
| Nov 4, 2025 | $3.16 | $3.01 | -4.7% | Miss | -17.0% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for INDP
See the fair value, the probability range and the earnings history of Indaptus Therapeutics on its ATLAS page.
Indaptus Therapeutics (INDP) stock analysisPlans from €3.99 a month.
Indaptus Therapeutics earnings: frequently asked questions
When does Indaptus Therapeutics (INDP) report earnings?
Indaptus Therapeutics is scheduled to report on Wednesday, November 11, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does INDP beat earnings estimates?
Of its last 5 reports with a recorded result, Indaptus Therapeutics beat the EPS estimate 3 times; the average surprise was -12.8%. Past results do not predict the next one.
How much does INDP move around earnings?
Over its last 5 reports the stock moved an average of 14.3% (absolute, from the close before the report day to the close after it), and finished higher 3 of 5 times.
Did Indaptus Therapeutics beat earnings estimates last quarter?
Indaptus Therapeutics last reported on May 27, 2026: EPS of $1.47 against an estimate of $1.28 (+14.8% surprise), a beat.
How much does INDP usually move in a day?
On a normal trading day the ATLAS model puts INDP’s one-day range at about ±8.6%, with a 48% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 11, 2026
Educational information, not investment advice. Disclaimer